We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

73 hedge funds and large institutions have $136M invested in Akebia Therapeutics in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 3 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,167% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 3

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

54% more capital invested

Capital invested by funds: $88.2M → $136M (+$47.5M)

20% more funds holding

Funds holding: 61 → 73 (+12)

11% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $952K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
73
Holders Change
+12
Holders Change %
+19.67%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
38
Reduced
3
Closed
9
Calls
$1.06M
Puts
$952K
Net Calls
+$104K
Net Calls Change
+$201K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.6M
2
EAM
Eagle Asset Management
Florida
+$10.2M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$5.88M
4
BFA
BlackRock Fund Advisors
California
+$4.4M
5
Marshall Wace
Marshall Wace
United Kingdom
+$3.41M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$6.64M
2
HM
HealthCor Management
New York
-$6.61M
3
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$221K
4
DP
Dearborn Partners
Illinois
-$200K
5
Swiss National Bank
Swiss National Bank
Switzerland
-$191K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$682K +$464K +54,417 +458%
NCCM
27
Nine Chapters Capital Management
New Jersey
$631K +$523K +61,300 New
Mirae Asset Global Investments
28
Mirae Asset Global Investments
South Korea
$623K -$221K -25,959 -30%
CS
29
Credit Suisse
Switzerland
$541K +$212K +24,801 +89%
ERSOT
30
Employees Retirement System of Texas
Texas
$515K – – –
Morgan Stanley
31
Morgan Stanley
New York
$496K -$65.2K -7,638 -14%
Charles Schwab
32
Charles Schwab
California
$460K +$203K +23,785 +114%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$458K +$256K +29,983 +206%
EA
34
Emerald Advisers
Pennsylvania
$442K – – –
TA
35
Teachers Advisors
New York
$386K +$226K +26,465 +239%
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$380K +$111K +13,000 +54%
ARTA
37
A.R.T. Advisors
New York
$364K +$157K +18,373 +108%
SIP
38
Stoneridge Investment Partners
Pennsylvania
$347K +$288K +33,706 New
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$308K +$255K +29,940 New
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$300K +$249K +29,147 New
AA
41
ALPS Advisors
Colorado
$294K +$158K +18,563 +185%
Millennium Management
42
Millennium Management
New York
$273K +$52.7K +6,172 +30%
ProShare Advisors
43
ProShare Advisors
Maryland
$269K +$70.1K +8,217 +46%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$260K +$36.2K +4,246 +20%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$257K +$213K +25,000 New
TC
46
TFS Capital
Pennsylvania
$222K +$184K +21,604 New
BA
47
BlackRock Advisors
Delaware
$218K +$149K +17,494 +475%
AL
48
Airain Ltd
Guernsey
$200K +$166K +19,480 New
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$194K +$161K +18,890 New
Goldman Sachs
50
Goldman Sachs
New York
$181K +$150K +17,616 New
1
2
3 4

AKBA Hedge Fund Activity: Q2 2015 in Review

73 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q2 2015, worth a combined $136M — up 54% from $88.2M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new AKBA positions and 9 closed out — a net gain of 12 holders — while 38 added to existing stakes and 3 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $10.6M. The largest seller was RA Capital Management, exiting entirely with an estimated $6.64M sold.

  • 73 institutional investors held Akebia Therapeutics (AKBA) as of Q2 2015, up from 61 in Q1 2015.
  • Funds reported $136M of Akebia Therapeutics stock for Q2 2015, up 54% quarter-over-quarter.
  • 21 funds opened new Akebia Therapeutics positions in Q2 2015 and 9 closed out, a net change of +12 holders.
  • The largest Akebia Therapeutics buyer in Q2 2015 was Fidelity Investments, an estimated $10.6M added.
  • The largest Akebia Therapeutics seller in Q2 2015 was RA Capital Management, an estimated $6.64M sold.

Based on aggregated 13F filings for Q2 2015.